Preservatives in eye drops.
D000438:Alcohols / Q000009:adverse effects; D001548:Benzalkonium Compounds / Q000009:adverse effects; D001565:Benzoates / Q000009:adverse effects; D002986:Clinical Trials as Topic; D004340:Drug Contamination / Q000517:prevention & control; D004348:Drug Labeling; D004349:Drug Packaging / Q000592:standards*; D005123:Eye / Q000187:drug effects; D006801:Humans; D008628:Mercury / Q000009:adverse effects; D009883:Ophthalmic Solutions / Q000592:standards*; D009942:Organometallic Compounds / Q000009:adverse effects; D010592:Pharmaceutic Aids / Q000009:adverse effects* / Q000592:standards; D012965:Sodium Chloride / Q000009:adverse effects; D013997:Time Factors
D000438:Alcohols; D001548:Benzalkonium Compounds; D001565:Benzoates; D009883:Ophthalmic Solutions; D009942:Organometallic Compounds; D010592:Pharmaceutic Aids; D012965:Sodium Chloride; D008628:Mercury